Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1R61MH138705-01 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Mental Health (NIMH) | NIH |
Not provided
Not provided
Not provided
Not provided
This study aims to understand the neural mechanisms that underlie synchronization of two brains during social interactions.
After being informed about the study and potential risks, all participants giving written informed consent will undergo a structural MRI image for anatomical localization of the targeted stimulation site. Participants will be randomly assigned to one of two TMS target locations, and will be identified for the TMS experiments. Two to three days prior to the TMS experiment, participants will undergo a before TMS/fNIRS experiment. On the day of the TMS experiment participants will undergo a functional dyadic neuroimaging session after TMS stimulation. For the neuromodulation experiments, tDCS, selected sites for stimulation will be identified on the T1 anatomical scans for each participant who will be randomly assigned to one of three groups. In each case the face-gaze fNIRS experiment will be run. Aim 2: Two targeted sites will be confirmed as neural hubs by modification of fiducial neural regions based on the findings of cTBS disruptions. Rationale: These locations and functional specializations are necessary for the proposed neuromodulation tests in the upcoming clinical trial phase.
Part 1: Stimulate to disrupt the site associated with eye-to-eye contact hypothesized to be right superior parietal lobule. Part 2: Stimulate to disrupt the site associated with live face gaze hypothesized to be right supramarginal gyrus.
The focus of this registration is Aim 2.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sham Comparator | Sham Comparator | TMS to a non-targeted region. |
|
| Experimental Comparator | Experimental | TMS to targeted regions |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Transcranial Magnetic Stimulation (TMS) | Device | TMS to targeted regions. Transcranial Direct Current Stimulation, tDCS, to targeted and sham regions. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percent change in hemodynamic signals | Statistical comparison of measures before and after stimulation. Measurement of brain oxygenation during cognitive assessment. The variable of interest will be changes in fNIRS oxyhemoglobin and deoxyhemoglobin signals (% change from baseline) during the cognitive assessment. | Baseline and At time of measurement, approximately one hour |
| Electroencephalography (EEG) response to live face gaze | Statistical comparison of measures before and after stimulation. EEG response to live face gaze is acquired for frequencies between 1 and 20 Hz. Oscillatory signals will be partitioned into Theta (4-8 Hz) and Alpha (8-12 Hz) frequencies for comparisons before and after TMS. Higher values indicate better score. | At time of measurement, approximately one hour |
| Eye Contact Behavior | Statistical comparison of measures before and after stimulation (amplitude). Free viewing Eye tracking measures are detected by light reflections acquired at 120 Hz. Eye to eye contact is computationally determined by comparison of the eye tracking measures between the two partners. | At time of measurement, approximately one hour |
| Face Gaze Behavior | Statistical comparison of measures before and after stimulation (Action Units). Facial dynamics are quantified by rapid photography and AI programs (OpenFace) that classify categories of facial expressions. There are 17 facial expressions that will be acquired during the face gaze conditions. | At time of measurement, approximately one hour |
Not provided
Not provided
Inclusion Criteria:
-Self reported typically developed adults.
Exclusion Criteria:
-No prior history of seizure activity. Self reported absence of recreational drugs at time of study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Joy Hirsch, PhD | Contact | 9174947768 | joy.hirsch@yale.edu |
| Name | Affiliation | Role |
|---|---|---|
| Joy Hirsch, PhD | Yale University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Yale School of Medicine | Recruiting | New Haven | Connecticut | 06511 | United States |
All data will be available on DRYAD, a public database
Upon completion of the study. The data will be available in perpetuity.
Access to the internet to access DRYAD.
Not provided
| ID | Term |
|---|---|
| D050781 | Transcranial Magnetic Stimulation |
| ID | Term |
|---|---|
| D055909 | Magnetic Field Therapy |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided